药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methyprylon
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Belinostat.
Methyprylon
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Belinostat.
Methyprylon
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Belinostat.
Methyprylon
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Belinostat.
Methyprylon
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Belinostat.
Methyprylon
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Belinostat.
Methyprylon
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Belinostat.
Methyprylon
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Belinostat.
Methyprylon
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Belinostat.
Methyprylon
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Belinostat.
Methyprylon
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Belinostat.
Methyprylon
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Belinostat.
Methyprylon
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Belinostat.
Methyprylon
Lumacaftor
The serum concentration of Belinostat can be decreased when it is combined with Lumacaftor.
Methyprylon
Fingolimod
Belinostat may increase the immunosuppressive activities of Fingolimod.
Methyprylon
Tofacitinib
Belinostat may increase the immunosuppressive activities of Tofacitinib.
Methyprylon
Vorinostat
The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Belinostat is combined with Vorinostat.
Methyprylon
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Belinostat.
Methyprylon
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Belinostat.
Methyprylon
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Belinostat.